Cafeic acid, a dietary polyphenol, as a promising candidate for combination therapy

Maity, Swastika and Kinra, Manas and Nampoothiri, Madhavan and Arora, Devinder and Pai, Sreedhara Ranganath K and Mudgal, Jayesh (2022) Cafeic acid, a dietary polyphenol, as a promising candidate for combination therapy. Chemical Papers, 76. pp. 1271-1283. ISSN 0366-6352

[img] PDF
15253DisplayPdf.pdf - Published Version
Restricted to Registered users only

Download (1MB) | Request a copy


Increased efectiveness and decreasing toxicity are prime objectives in drug research. Overwhelming evidence suggests the use of appropriate combination therapy for the better efcacy of drugs owing to their synergistic profle. Dietary active constituents play a major role in health outcomes. Therefore, it is possible to increase the efectiveness of the drug by combining contemporary medication with active natural/semi-synthetic constituents. One such dietary constituent, cafeic acid (CA),is a by-product of the shikimate pathway in plants and is a polyphenol of hydroxycinnamic acid class.Extensive research on CA has proposed its efcacy against infammatory, neurodegenerative, oncologic, and metabolic disorders.The synergistic/additive efects of CA in combination with drugs like cafeine, metformin, pioglitazone, and quercetin have been reported in several experimental models and thus the present review is an attempt to consolidate outcomes of this research. Multitarget-based mechanistic studies will facilitate the development of efective combination regimens of CA

Item Type: Article
Uncontrolled Keywords: Cafeic acid; Combination therapy; Cafeine; Metabolic disorders; Bioactive metabolites
Subjects: Pharmacy > MCOPS Manipal > Pharmacology
Depositing User: KMC Library
Date Deposited: 06 Jun 2022 12:23
Last Modified: 06 Jun 2022 12:23

Actions (login required)

View Item View Item